Chemotherapy
499 articles
A Potential Role for PARP Inhibitors in Pancreatic Cancer
Dr. Michael Pishvaian leads research into the possible role of PARP inhibitors in treating pancreatic cancer patients with certain genetic mutations.
Aiming to Improve Immunotherapy for Pancreatic Cancer
Dr. Deirdre Cohen discusses clinical trials that aim to improve the effectiveness of immunotherapy for pancreatic cancer.
MRI-Guided Radiation: A New Option for Pancreatic Cancer Treatment
Dr. Parag Parikh and others are using MRI-guided radiation to provide precision radiation treatment for pancreatic cancer.
Damage as a Way to Repair Pancreatic Cancer
Dr. Talia Golan takes a closer look at the damage caused by the BRCA1/2 mutations to find a way to treat pancreatic cancer.
Using Tumor Tissue Samples to Break Down Assumptions About Pancreatic Cancer
Dr. Christine Iacobuzio-Donahue uses tumor tissue samples to study how pancreatic cancer tumors develop, so she can find ways to stop the disease.
For Pancreatic Cancer Patients, Pain Control Through Targeted Radiotherapy
Dr. Yaacov Lawrence is using celiac plexus radiotherapy in a clinical trials to target a source of pain for pancreatic cancer patients.
High-Dose Vitamin C Targeting KRAS and BRAF in Pancreatic Cancer
Learn how Dr. Manish Shah is leading clinical trials using high-dose Vitamin C to target KRAS and BRAF mutations in pancreatic cancer.
DIRECT Study Focuses on NanoKnife Technology
Dr. Daniel Holzwanger is part of the NanoKnife irreversible electroporation (IRE) study for stage III pancreatic cancer patients.
Tumor Subtypes Potentially Provide Clues About Prognosis and Treatment
Drs. Andrew Aguirre and David Ting are teasing out the differences between pancreatic cancer subtypes, to get treatments that work better.
AACR Annual Meeting 2021 Highlights
Let’s Win and the Lustgarten Foundation bring you the pancreatic cancer research highlights of the 2021 AACR Annual Meeting,
Finding More Clues about Circulating Tumor DNA
Researcher Dr. Gehan Botrus looks at circulating tumor DNA for genetic information on a patient’s pancreatic cancer to personalize treatment.
KRYSTAL-1 Trial Shows Promising Activity in Pancreas and Other GI Cancers
Dr. Tanios Bekaii-Saab reports promising results of the KRYSTAL-1 trial, which targets a KRAS mutation common to pancreatic cancer.
Access and Disparities in Pancreatic Cancer Surgery Remain Pervasive Problems
Dr. Susan Tsai discusses her research into the causes of pancreatic cancer surgery and treatment disparities for underserved communities.
mRNA Vaccine Shows Promising Results
Dr. Vinod Balachandran is testing an mRNA vaccine for pancreatic cancer using the same technology as COVID vaccines.
Let’s Win: Innovative Online Community Offers Guidance to Patients With Pancreatic Cancer and Their Families
The ASCO Post, a news publication of the American Society of Clinical Oncology, features Let’s Win and its mission to help pancreatic cancer patients.